Ginger: Panacea or Consumer’s Hype?

• Main Author: Susana Santos Braga
• Format: Article
• Language: English
• Published: MDPI AG 2019-04-01
• Series: Applied Sciences
• Subjects: bioavailability; medication interactions; clinical trials; encapsulation; nano-carriers
• Online Access: https://www.mdpi.com/2076-3417/9/8/1570

Ginger in its many forms, from juices of the fresh rhizome, to ginger powder and ginger essential oil, is growing in popularity for claimed universal health benefits. Nevertheless, and contrarily to the common notion of the public, ginger is not devoid of side effects, especially interactions with other drugs, and many of the claimed benefits remain to be substantiated. This work presents a comprehensive revision of the current state of the art on ginger pharmacokinetics and bioavailability, interaction with active pharmaceutical ingredients, raising awareness of the risks of uncontrolled ginger consumption. A second section of the work described the verified actions of various extracts of ginger, or of their main active ingredients, gingerols, based mainly on data obtained from controlled clinical trials. Finally, the last section is devoted to innovative technological solutions to improve the bioavailability of gingerols and ginger extracts that are expected to ultimately lead to the development of more consumer-compliant products.